Tech Company Financing Transactions
Lewis and Clark Pharmaceuticals Funding Round
On 10/23/2013, Lewis and Clark Pharmaceuticals secured $375 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
10/23/2013
Transaction Type
Venture Equity
Amount
$375,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1180 Seminole Trail 495
Charlottesville, VA 22901
USA
Charlottesville, VA 22901
USA
Phone
Website
Email Address
Not Recorded
Overview
The company develops adenosine-based pharmaceutical compounds for autoimmune disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Thompson
Chief Scientific Officer
Larry Rodman
Browse more venture capital transactions:
Prev: 10/23/2013: Cureatr venture capital transaction
Next: 10/24/2013: Formlabs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs